Sugi Holdings Co.,Ltd.
Sugi Holdings Co.,Ltd.
- Market cap
- $2.95B
- P/E ratio
- 17.41
Your view on SGIPF
Overview
What the company does, where it operates, and who runs it.
About Sugi Holdings Co.,Ltd.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Katsunori Sugiura
- Headquarters
- 62-1 Shine Yokonemachi, Obu, JP
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Katsunori Sugiura
- Headquarters
- 62-1 Shine Yokonemachi, Obu, JP
Sugi Holdings Co.,Ltd. operates drugstores in Japan. It also provides health counseling services; home-visit prescription dispensing and nursing services; medical consulting; staff agency services; disabled employment promotion; and elderly home care support services.
The company operates approximately 1,483 drugstores. Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Sugi Holdings Co.,Ltd.. Starting points for Sugi Holdings Co.,Ltd.: P/E 17.4, EPS $80.14, beta 0.45 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Sugi Holdings Co.,Ltd.. Sugi Holdings Co.,Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Sugi Holdings Co.,Ltd.. Trailing twelve-month EPS for Sugi Holdings Co.,Ltd. stands at $80.14. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterNov 2026 | Next quarterFeb 2027 | This yearYear to Feb 2027 | Next yearYear to Feb 2028 |
|---|---|---|---|---|
| Average estimate | JPY 20.38 | JPY 17.96 | JPY 79.35 | JPY 94.17 |
| Lowest estimate | JPY 19.38 | JPY 17.08 | JPY 76.37 | JPY 90.63 |
| Highest estimate | JPY 21.38 | JPY 18.84 | JPY 81.79 | JPY 97.06 |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | JPY 0.251 | JPY 0.331 | JPY 248.921 | — |
| Growth vs a year ago | — | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterNov 2026 | Next quarterFeb 2027 | This yearYear to Feb 2027 | Next yearYear to Feb 2028 |
|---|---|---|---|---|
| Average estimate | JPY 273.83B | JPY 304.50B | JPY 1.12T | JPY 1.24T |
| Lowest estimate | JPY 260.69B | JPY 295.67B | JPY 1.11T | JPY 1.18T |
| Highest estimate | JPY 284.03B | JPY 316.12B | JPY 1.12T | JPY 1.30T |
| Number of analysts | 5 | 5 | 5 | 8 |
| A year ago | JPY 249.51B | JPY 260.96B | JPY 1.01T | — |
| Growth vs a year ago | +9.7% | +16.7% | +10.1% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Sugi Holdings Co.,Ltd.. Sugi Holdings Co.,Ltd. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CSMYFCOSMOS Pharmaceutical Corporation | Healthcare | OTC | $3.8B | ||
| CTORCitius Oncology, Inc. | Healthcare | NASDAQ | $51.8M | ||
| CTTHCTT Pharmaceutical Holdings, Inc. | Healthcare | OTC | $1.9M | ||
| CUVLClinuvel Pharmaceuticals Ltd. | Healthcare | NASDAQ | $245.1M | ||
| CXBSCorix Bioscience, Inc. | Healthcare | OTC | $2,734 | ||
| CYBN.NECybin Inc. | Healthcare | NEO | — | ||
| DECNDecision Diagnostics Corp. | Healthcare | OTC | $35,450 | ||
| DOSEFDoseology Sciences Inc. | Healthcare | OTC | $1.7M | ||
| EBM.VEastwood Bio-Medical Canada Inc. | Healthcare | TSXV | $44.1M | ||
| ECGSEco-Growth Strategies Inc. | Healthcare | OTC | $3.7M | ||
| ERGOEntia Biosciences, Inc. | Healthcare | OTC | $10,098 | ||
| ETBIEastgate Biotech Corp. | Healthcare | OTC | $2.1M | ||
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Sugi Holdings Co.,Ltd.